Tarsus Pharmaceuticals, Inc.

Healthcare · Biotechnology · United States

Last price 74.85 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 3.28B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States. The company offers XDEMVY, a lotilaner ophthalmic solution for the treatment of demodex blepharitis caused by the infestation of Demodex mites. It sells its products to specialty pharmacies and distributors, as well as clinics, hospitals, pharmacies, and federal healthcare programs. The company also develops TP-04, a sterile aqueous gel formulation of lotilaner ...